Skip to main content

What is the difference between Cyltezo and Humira?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 26, 2025.

Official answer

by Drugs.com

Cyltezo (adalimumab-adbm) is an FDA-approved interchangeable biosimilar to Humira (adalimumab). Both medications are anti-TNF-α monoclonal antibodys used for the treatment of multiple conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

What Is a Biosimilar?

A biosimilar is a product that is highly similar to an FDA-approved biologic (reference product) with no clinically meaningful differences in safety, purity, or potency.

  • Interchangeable biosimilars undergo additional FDA studies to confirm that switching between the biosimilar and reference product does not affect safety or effectiveness.
  • Pharmacists may substitute Cyltezo for Humira without prescriber approval, subject to state laws.

FDA-Approved Humira Biosimilars

Cyltezo (adalimumab-adbm) was the second Humira (adalimumab) biosimilar approved by the FDA. Other biosimilars to Humira include:

  • Amjevita (adalimumab-atto)
  • Hyrimoz (adalimumab-adaz)
  • Hadlima (adalimumab-bwwd)
  • Abrilada (adalimumab-afzb)
  • Hulio (adalimumab-fkjp)
  • Idacio (adalimumab-aacf)
  • Simlandi (adalimumab-ryvk)
  • Yusimry (adalimumab-aqvh)
  • Yuflyma (adalimumab-aaty)

Is Cyltezo citrate-free?

Yes, Cyltezo is citrate-free. Most newer Humira biosimilars omit citrate, reducing injection-site pain.

Approved Uses: Cyltezo vs. Humira

The approved indications for Humira and Cyltezo are the same, with variations in population groups.

Like Humira, Cyltezo is used for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

The following table compares the approved indications for Humira and Cyltezo:

Indication Humira Cyltezo
Rheumatoid Arthritis (RA) adults adults
Juvenile Idiopathic Arthritis (JIA) patients 2 years of age
and older
patients 2 years of age
and older
Psoriatic Arthritis (PsA) adults adults
Ankylosing Spondylitis (AS) adults adults
Crohn’s Disease (CD) patients 6 years of age and older patients 6 years of age and older
Ulcerative Colitis (UC) patients 5 years of age and older adults
Plaque Psoriasis (Ps) adults adults
Hidradenitis Suppurativa (HS) patients 12 years of age and older adults
Uveitis (UV) patients 2 years of age and older adults

Cyltezo is an interchangeable biosimilar to Humira. A biosimilar with an Interchangeable designation can be auto-substituted by a pharmacist for the reference product.

Related questions

How Are Cyltezo and Humira Administered?

Cyltezo and Humira are both administered via subcutaneous injection, meaning they are injected under the skin.

  • Cyltezo is available as a single-dose prefilled syringe and a single dose prefilled pen
  • Humira is available as a single-dose prefilled pen, prefilled syringe, and single-dose vial.

Key Takeaways

  • Cyltezo is an interchangeable biosimilar to Humira, meaning pharmacists can substitute it without prescriber approval in some states.
  • Both medications are used to treat similar conditions, with slight differences in age group approvals.
  • Both are given as subcutaneous injections, but Humira has more formulation options.

See What Are Biosimilars? Top Facts You May Not Know

References
  • U.S. Food and Drug Administration. HUMIRA Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125057s417lbl.pdf [Accessed September 20, 2023]
  • U.S. Food and Drug Administration. CYLTEZO Product Label. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761058s018lbl.pdf [Accessed September 20, 2023]
  • U.S. Food and Drug Administration. What is a Biosimilar? Available at https://www.fda.gov/media/108905/download [Accessed March 2, 2021]

Read next

Does Humira cause weight gain or weight loss?

The manufacturer of Humira does not list weight gain or weight loss as a possible direct side effect associated Humira. However, other conditions, symptoms, or medications may affect your weight while you are using this medication. Clinical studies have also shown weight gain with Humira. Continue reading

How long does it take for Humira to work?

Most patients will start to feel relief from their symptoms within 2 to 12 weeks. Your results will vary based on your condition being treated and other factors, such as tolerability to treatment and other medications you may be using. Continue reading

How long can Humira be out of the fridge?

If you are traveling or not able to keep your Humira in the refrigerator, you can store it at room temperature up to a maximum of 77 degrees F (25 degrees C) for a period of up to 14 days. Once your Humira Pen or prefilled syringe has reached room temperature, it must be used within 14 days even if it is put back in the refrigerator. Continue reading

Related medical questions

Drug information

Related support groups